Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med

12th July 2017 Uncategorised 0

All eyes in the drug industry turned to the FDA’s Oncologic Drugs Advisory Committee meeting Wednesday, where Novartis won crucial backing for its potentially groundbreaking lead CAR-T drug.

More: Novartis wins unanimous support from FDA panel on groundbreaking CAR-T med
Source: fierce